Underreporting of Myeloid Malignancies by United States Cancer Registries
暂无分享,去创建一个
[1] C. Cogle,et al. Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes. , 2011, Leukemia research.
[2] Xianglin L. Du,et al. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non‐Hodgkin lymphoma , 2010, Cancer.
[3] H. Deeg,et al. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005–2006 , 2010, American journal of hematology.
[4] M. Laouri,et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Karan P. Singh,et al. Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma. , 2010, Cancer epidemiology.
[6] M. Ellis,et al. Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study , 2009, Breast Cancer Research and Treatment.
[7] N. Howlader,et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. , 2008, Blood.
[8] H. Brenner,et al. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century , 2008, Haematologica.
[9] G. Hortobagyi,et al. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Jian Wang,et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. , 2007, Journal of the National Cancer Institute.
[11] G. Gatta,et al. Adult acute myeloid leukaemia. , 2004, Critical reviews in oncology/hematology.
[12] C. Bloomfield,et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Deborah Schrag,et al. Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.
[14] U. Germing,et al. Epidemiological Features of Myelodysplastic Syndromes: Results From Regional Cancer Surveys and Hospital-Based Statistics , 2001, International journal of hematology.
[15] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.